Literature DB >> 21173618

Update on prognostic genetic testing in adolescent idiopathic scoliosis (AIS).

James W Ogilvie1.   

Abstract

Case-control genome-wide association studies using a large, geographically diverse data base has been used to identify single nucleotide polymorphisms that have prognostic utility in predicting progression of mild adolescent idiopathic scoliosis in White patients. The calculated risk of progression score allows stratification of patients that can make medical care evidence based, less costly, and more efficient.

Entities:  

Mesh：

Year:  2011        PMID： 21173618     DOI： 10.1097/BPO.0b013e3181fd87eb

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN： 0271-6798            Impact factor:   2.324


  9 in total

1.  BMPER variants associated with a novel, attenuated subtype of diaphanospondylodysostosis.

Authors:  Zheyuan Zong; Susan Tees; Firoz Miyanji; Clarissa Fauth; Christopher Reilly; Elena Lopez; Stephen Tredwell; Yigal Paul Goldberg; Allen Delaney; Patrice Eydoux; Margot Van Allen; Anna Lehman
Journal:  J Hum Genet       Date:  2015-10-15       Impact factor: 3.172

Review 2.  Idiopathic scoliosis: etiological concepts and hypotheses.

Authors:  Romain Dayer; Thierry Haumont; Wilson Belaieff; Pierre Lascombes
Journal:  J Child Orthop       Date:  2013-01-29       Impact factor: 1.548

Review 3.  2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Sabrina Donzelli; Angelo Gabriele Aulisa; Dariusz Czaprowski; Sanja Schreiber; Jean Claude de Mauroy; Helmut Diers; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Andrea Lebel; Cindy Marti; Toru Maruyama; Joe O'Brien; Nigel Price; Eric Parent; Manuel Rigo; Michele Romano; Luke Stikeleather; James Wynne; Fabio Zaina
Journal:  Scoliosis Spinal Disord       Date:  2018-01-10

4.  Adolescent idiopathic scoliosis (AIS), environment, exposome and epigenetics: a molecular perspective of postnatal normal spinal growth and the etiopathogenesis of AIS with consideration of a network approach and possible implications for medical therapy.

Authors:  R Geoffrey Burwell; Peter H Dangerfield; Alan Moulton; Theodoros B Grivas
Journal:  Scoliosis       Date:  2011-12-02

5.  2011 SOSORT guidelines: Orthopaedic and Rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Angelo G Aulisa; Lorenzo Aulisa; Alin B Circo; Jean Claude de Mauroy; Jacek Durmala; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Toru Maruyama; Silvia Minozzi; Joseph P O'Brien; Dimitris Papadopoulos; Manuel Rigo; Charles H Rivard; Michele Romano; James H Wynne; Monica Villagrasa; Hans-Rudolf Weiss; Fabio Zaina
Journal:  Scoliosis       Date:  2012-01-20

6.  Transforming growth factor-beta (TGF- β) signaling in paravertebral muscles in juvenile and adolescent idiopathic scoliosis.

Authors:  Roman Nowak; Magdalena Kwiecien; Magdalena Tkacz; Urszula Mazurek
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

7.  Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patients.

Authors:  Roman Nowak; Justyna Szota; Urszula Mazurek
Journal:  BMC Musculoskelet Disord       Date:  2012-12-23       Impact factor: 2.362

8.  Whither the etiopathogenesis (and scoliogeny) of adolescent idiopathic scoliosis? Incorporating presentations on scoliogeny at the 2012 IRSSD and SRS meetings.

Authors:  R Geoffrey Burwell; Peter H Dangerfield; Alan Moulton; Theodoros B Grivas; Jack Cy Cheng
Journal:  Scoliosis       Date:  2013-02-28

9.  A New Look at Etiological Factors of Idiopathic Scoliosis: Neural Crest Cells.

Authors:  Alla M Zaydman; Elena L Strokova; Elena V Kiseleva; Lubov A Suldina; Anton A Strunov; Alexander I Shevchenko; Pavel P Laktionov; Vladimir M Subbotin
Journal:  Int J Med Sci       Date:  2018-03-06       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.